Synergism of combined lithium-neuroleptic therapy: a double-blind, placebo-controlled case study.
L B Bigelow, D R Weinberger, R J Wyatt
Index: Am. J. Psychiatry 138(1) , 81-3, (1981)
Full Text: HTML
Abstract
The authors describe a longitudinal, placebo-controlled study of the response to drug treatment of a 62-year-old schizoaffective patient hospitalized for 40 years. While neither lithium nor a neuroleptic drug alone was effective, both drugs administered simultaneously led to the gradual extinction of a pronounced behavioral cycle and the disappearance of manifest psychosis. The authors suggest a synergistic interaction between the two drugs and stress the need for sustained trials of the combination in patients with similar behavioral cycles.
Related Compounds
Related Articles:
[CLINICAL OBSERVATIONS ON THE ACTION OF TINDAL IN PSYCHIATRIC TREATMENT].
1964-01-01
[Neurol. Neurochir. Psychiatr. Pol. 14 , 683-6, (1964)]
HEMODYNAMIC EFFECTS OF IMIPRAMINE, ACETOPHENAZINE, AND TRIFLUOPERAZINE IN GERIATRIC PSYCHIATRY.
1965-07-01
[Dis. Nerv. Syst. 26 , 427-9, (1965)]
BEHAVIORAL IMPROVEMENT IN THE OLDER SCHIZOPHRENIC PATIENT: DRUG AND SOCIAL THERAPIES.
1965-01-01
[J. Am. Geriatr. Soc. 13 , 57-72, (1965)]
CHEMOTHERAPY FOR EMOTIONALLY DISTURBED CHILDREN: A FOLLOW-UP REPORT.
1964-12-01
[Dis. Nerv. Syst. 25 , 735-8, (1964)]
OBSERVATIONS ON ACETOPHENAZINE.
1964-10-01
[Am. J. Psychiatry 121 , 387-8, (1964)]